key: cord-0992592-hehvdfvo authors: Hamer, Davidson H; Rizwan, Aisha; Freedman, David O; Kozarsky, Phyllis; Libman, Michael title: GeoSentinel: past, present and future date: 2020-11-27 journal: J Travel Med DOI: 10.1093/jtm/taaa219 sha: 0a756160bdf84aa7a575114d5d22be3143be01a8 doc_id: 992592 cord_uid: hehvdfvo RATIONALE FOR REVIEW: In response to increased concerns about emerging infectious diseases, GeoSentinel, the Global Surveillance Network of the International Society of Travel Medicine in partnership with the US Centers for Disease Control and Prevention (CDC), was established in 1995 in order to serve as a global provider-based emerging infections sentinel network, conduct surveillance for travel-related infections and communicate and assist global public health responses. This review summarizes the history, past achievements and future directions of the GeoSentinel Network. KEY FINDINGS: Funded by the US CDC in 1996, GeoSentinel has grown from a group of eight US-based travel and tropical medicine centers to a global network, which currently consists of 68 sites in 28 countries. GeoSentinel has provided important contributions that have enhanced the ability to use destination-specific differences to guide diagnosis and treatment of returning travelers, migrants and refugees. During the last two decades, GeoSentinel has identified a number of sentinel infectious disease events including previously unrecognized outbreaks and occurrence of diseases in locations thought not to harbor certain infectious agents. GeoSentinel has also provided useful insight into illnesses affecting different traveling populations such as migrants, business travelers and students, while characterizing in greater detail the epidemiology of infectious diseases such as typhoid fever, leishmaniasis and Zika virus disease. CONCLUSIONS: Surveillance of travel- and migration-related infectious diseases has been the main focus of GeoSentinel for the last 25 years. However, GeoSentinel is now evolving into a network that will conduct both research and surveillance. The large number of participating sites and excellent geographic coverage for identification of both common and illnesses in individuals who have traversed international borders uniquely position GeoSentinel to make important contributions of travel-related infectious diseases in the years to come. Despite improvements in the global burden, morbidity and mortality from infectious diseases over the last two decades, emerging and re-emerging infections continue to present major threats to populations worldwide. 1,2 Global movement of persons whether for tourism, business or migration 3 -5 ; effects of climate change on the environment; greater host susceptibility for many reasons; and genetic evolution of pathogens all play a role in the emergence (or re-emergence) of pathogens and the appearance and spread of novel diseases. 1,6-8 An estimated 60% or more of emerging infectious diseases are zoonotic. 9 In addition, there has been a substantial rise in antimicrobial resistance (AMR) in resource-limited areas of the world 10, 11 and spread of these multi-drug resistant organisms via travelers to their home countries. 12 Returning travelers seen at sentinel sites by collaborative provider networks such as GeoSentinel 13,14 provide insight into the transmission and spread of infectious diseases. GeoSentinel, the Global Surveillance Network of the International Society of Travel Medicine (ISTM) in partnership with the US Centers for Disease Control and Prevention (CDC), consists of specialized travel and tropical medicine clinics that are ideally situated to detect emerging infections and to track ongoing trends in travel-related illness. Currently, the primary objectives of GeoSentinel are to: (i) operate a global provider-based emerging infections sentinel network; (ii) conduct surveillance for travelrelated infections; and (iii) communicate and help guide public health responses. During a 1-day meeting in Atlanta in the summer of 1995, Phyllis Kozarsky, David Freedman and Martin Cetron decided to recruit a working group of eight US-based ISTM member travel clinics run by trusted and eminent colleagues to establish a unique surveillance network. GeoSentinel was designed to track emerging infectious diseases at their point of entry into domestic populations, monitor global trends in disease occurrence among travelers, and respond to urgent public health queries. The network was also developed to aid in rapid response by electronically disseminating alerts to surveillance sites, to all ISTM members worldwide and to partner organizations globally. The vision of the then ISTM President Jay Keystone led to the ISTM providing 50 000 USD seed money to develop the network until independent funding could be secured. By May 1996 GeoSentinel was awarded competitive funding through the CDC Division of Quarantine (Table 1) , under a US initiative to strengthen surveillance and response to emerging pathogens as strongly suggested by the Institute of Medicine in their 1992 report. By the end of 1997, GeoSentinel went 'live' at participating surveillance sites using a set of data fields that linked destination, date of travel and disease diagnosis in returning travelers. GeoSentinel was expanded internationally and data from all sites were manually aggregated at an Atlanta data center. In 1998, the group began to host annual Site Directors meetings at different locations around the world which brought together the combined expertise and intellect of many of the key leaders in the field of travel medicine and which continue as an epicenter for the development and advancement of research in the field. In 2020, instantaneous global sharing of information around disease outbreaks is taken for granted. This has been welldemonstrated during the COVID-19, Ebola, Middle East respiratory virus, severe acute respiratory syndrome (SARS) and H1N1 pandemic influenza outbreaks that have occurred in recent years. However, in September 2000, GeoSentinel, which by then had expanded to 26 sites on all continents, provided one of the first demonstrations of the beginning of the exciting adventure in the way global surveillance data can rapidly be turned into information for action. The Borneo Eco-Challenge leptospirosis outbreak 15 ,16 demonstrated that the growth of partnerships between ISTM, CDC, and other medical societies, governments and private organizations had become one of the surveillance network's greatest assets. This outbreak also demonstrated the value of front-line clinical observations by expert clinicians and the ability of the doctor-patient relationship to rapidly translate into meaningful public health information. The reporting and documentation of patients seen with this unusual illness by network sites in London, Toronto, New York and Melbourneall in <24 hours-could not have been accomplished otherwise. In 2003, the GeoSentinel site in Toronto saw some of the first SARS cases outside Asia and quickly notified the network that SARS was not just an Asian problem as per the WHO alerts but was now a global problem that demanded a public health response. A comprehensive analysis of 17 000 ill returned travelers from the developing world, published in 2006, summarized the GeoSentinel experience between 1996 and 2004 and provided a blueprint for all medical providers of what diagnoses to consider in ill travelers, based on from where they returned (Table 1) . 17 Physicians were able for the first time to use destination-specific differences to guide diagnosis and treatment of these individuals. This paper has been cited in the medical literature over 1000 times, a record for travel medicine, and still receives at least 10 citations per year ( Table 2 ). In 2007, the second generation GeoSentinel Data Entry and Reporting web application went live. For the first time, patient records entered at any site worldwide, 24 hours a day, were immediately live on a secure database, accessible for viewing on-screen in real time by project directors. In 2008, 12 European GeoSentinel sites formed a consortium and launched Euro-TravNet, a new ISTM initiative in Europe funded by a new partnership with the European Centre for Disease Prevention and Control (ECDC) in Stockholm. The partnership helped aid communications between sites in Europe and those elsewhere. 53 GeoSentinel sites in 24 countries was published. 13 Once again, clinicians were able to use these 5-year GeoSentinel data to help tailor more efficient pretravel preparation strategies and evaluate possible differential diagnoses of ill returned travelers according to destination and reason for travel. With surveillance data The data collection protocol for GeoSentinel has been reviewed by the CDC's National Center for Emerging and Zoonotic Infectious Diseases and has been classified as public health surveillance and therefore ethics committee review is not required. Sites obtain additional ethical clearance as required by their respective institutions. Only individuals who have crossed an international border are eligible for inclusion in the GeoSentinel database. GeoSentinel surveillance data are collected using a standardized case report form and include physician-confirmed patient diagnoses and country of exposure along with more detailed exposure information, chronology of travel, symptom data and antibiotic susceptibility data. Returning travelers and migrants seen at GeoSentinel sites serve as sentinels-they provide a sample of disease agents that may be acquired in 249 countries and territories. Data reported by the sentinel Sites are entered online into a secure central database ( Figure 1 ). Data are reviewed routinely for unusual patterns suggestive of disease outbreaks and novel findings such as the occurrence of a disease in an unexpected location. In addition to daily review of all submitted records, various quality control measures are continuously performed to strengthen the quality of the data. Between 2015 and 2018, the Data Collection WG reviewed and revised all the disease codes (diagnostic criteria for each disease); updated the core surveillance data collection; and developed strategies for data quality control. The Special Populations WG developed several studies with enhanced data collection on defined groups, such as those individuals who received postexposure prophylaxis for rabies, 18 mass gathering attendees, 19 those who experienced unanticipated and unplanned medical care during travel, 20 and those migrants who were screened for infections on arrival at their destinations. 21 The Enhanced Clinical Surveillance WG spearheaded the initiation of several studies including the SEVere, undiagnosed infections in returning TRAVelers (SEVTRAV) study which has been designed to define etiologies of febrile illness in travelers and migrants and novel pathogen discovery when the cause of illness is not identified. The Chikungunya, Dengue, Zika and Malaria (CHIDEZ-IMA) project is also ongoing and was designed to assess the medium-term impact of the physical and psychosocial aspects of these four diseases. The Tracking and Communications WG has been responsible for identifying potential sentinel or important travel-or migration-related events and communicating them to ProMED and to public health authorities (e.g. During the last 25 years, the GeoSentinel Surveillance Network has been highly productive. 22 Recent GeoSentinel articles continue to be frequently cited (Table 3) . Some notable analyses of travel-related infections in recent years include descriptions of specific diseases including leishmaniasis, 23 travel-associated pertussis, 24 Clostridium difficile in travelers, 25 leptospirosis, 26 hepatitis E, 27 and enteric fever including AMR data for Salmonella enterica serovar Typhi and S. Paratyphi. 28 There have also been analyses of travel-specific destinations including common febrile illnesses in West African countries confronted with the Ebola outbreak, 29 travelers to the USA 30 and illness among travelers to Brazil. 31 In addition, there have been a number of analyses on special populations such as student travelers, 32 travelers visiting friends and relatives, 33 European travelers, 34 skin diseases among Canadian travelers 35 and animal exposures among travelers 36 as well as migrant health, e.g. US migrants, 37 the spectrum of illness in Syrian migrants 38 and malaria in Eritrean migrants. 39 In addition, there have been several analyses focused on emerging and re-emerging diseases, e.g. the arrival of Zika virus disease in the Americas, 40 Zika outside of the Western Hemisphere 41 ; and measles, 42,43 the importance of which has recently been emphasized. In addition to the global, regional and disease-specific analyses, GeoSentinel has identified many sentinel events during the last two decades (Table 4 ). In addition to the aforementioned outbreak of leptospirosis at the Eco-Challenge in Borneo, 15 some notable sentinel events have included the identification of dengue in Angola, 44 sarcocystis in Malaysia, 45 schistosomiasis in Corsica, 46 yellow fever in southern Brazil 47 and chikungunya in southern Thailand, Myanmar and the Maldives. 48-50 These events were communicated to relevant public health authorities. Recent strategic planning discussions, within and outside the network, have focused on making substantive changes in the nature of future projects. The GeoSentinel network remains uniquely valuable as a platform for understanding the emergence and movement of infectious diseases around the globe. It is first and foremost a network of people, bringing together many of the world's recognized experts in travel and tropical health. These experts are backed by the resources of their associated academic institutions, which include the material resources for diagnosing and characterizing both common and esoteric infections, and the scholarly resources for driving new project development and success. The network has access to laboratory expertise in every relevant discipline, renowned researchers in epidemiology and clinical sciences, and globally recognized expert clinicians who provide the interface with ill travelers. Finally, the network has a truly worldwide catchment, with sites across world providing care to large numbers of travelers of every type returning from every region of the globe. In recent years, it has become apparent that the network needed to move beyond sentinel surveillance and retrospective review of surveillance data. Over the past 25 years, communication networks for transmitting surveillance information have multiplied in nature and speed, diluting GeoSentinel's unique advantages in this regard. Many of the analyses of the database concentrated on 'who gets what where' questions, both broadly speaking as well as focused on specific illnesses and syndromes. As described above, some of these larger analyses provided for the first time a detailed understanding of the epidemiology of imported infections, replacing information which had previous been gleaned from single center reviews, or small collaborations. 13,17 It has also become evident that the basic epidemiology of many of the illnesses investigated is not changing in the shortterm, and that broadening the scope of GeoSentinel's mission would be important for future discoveries. The first step forward was the development of the enhanced surveillance projects described above. Rather than simply mining the accumulated data, looking for patterns, the orientation shifted toward identifying gaps in knowledge, and designing prospective data collection instruments to be able to answer more relevant questions. This approach led to a number of successful projects. 18-20 Nevertheless, projects were restricted in scope owing to the need to restrict the information collected to surveillance data, linked to routine patient care. Sentinel surveillance continues to be where GeoSentinel excels. Despite advances in low cost diagnostics, many regions of the world still do not have sufficient human and material infrastructure to optimally survey endemic and emerging diseases. Using individuals who have traversed international borders to 'sample' local transmission remains critical and maintaining a geographically extensive and high patient volume network will continue to be an invaluable resource. Antibiotic susceptibility surveillance will also remain important. In the future, more sophisticated technology will be added to assist in interpreting data, and techniques using machine learning are likely to improve the ability to signal sentinel eventsinfections emerging in unexpected locations, unusual clusters and unanticipated trends-all signals which can trigger a more focused investigation. The next step in understanding imported infections will necessarily involve developing a more traditional research-based approach including the use of molecular epidemiology. Even simple modifications of the existing enhanced surveillance model with the addition of questionnaires, more detailed clinical outcomes data, and project driven collection of biologic samples greatly expands the potential for advances in the field. More detailed clinical information, serosurveys and biomarkers are examples of relatively inexpensive data which can enhance our understanding of risks, costs and populations to target for interventions. The network is also well positioned for comparative evaluations of laboratory diagnostics, markers of illness outcomes and interventions. In this domain, the network strength lies in numbers and breadth of catchment. Rare infections can be captured in sufficient volume for analysis. Common infections, such as malaria or dengue, can now be stratified by geographic Returning travelers provided an early warning signal of a chikungunya outbreak in Myanmar exposure, variants of clinical presentation and mechanisms of treatment and follow-up. Recently, the network has completed an internal survey of the research capacity and technical resources at each site. Some studies, such as controlled trials, may be feasible at single sites or through collaborations, but GeoSentinel has the advantage of being able to create customized 'subnetworks' which are well adapted for these types of projects, based on local expertise, lab capacity and detailed knowledge of the local patient population. Insight into these new avenues for network development has led the CDC to modify their funding opportunity to include research, as well as surveillance activities. Simultaneously, the network has worked on expanding its sources of funding to be able to support the unavoidably higher costs of research projects. Investigators within the network have applied for peerreviewed funding for several projects. GeoSentinel has set up collaborations with other funded researchers to bring the broad data gathering capacity of the network together with established expertise at other institutions. Fundraising through philanthropic donations to the GeoSentinel Foundation, a new charitable foundation dedicated to the support of GeoSentinel projects and led by Dr Bradley Connor, a long-time GeoSentinel site director, has already been highly successful as the general public becomes increasing aware of the need to better detect and understand transmission and importation of infections, emerging and established. COVID-19 has had a major impact on GeoSentinel, by virtue of the massive decline in travel and migration which has severely limited the network's ability to 'sample' imported infections. Although we expect effects of the pandemic to be temporary and for travel to resume, the time this will require is unpredictable, and will likely depend on the widespread distribution of an effective vaccine. However, the pandemic has also been an opportunity for the network to examine COVID-19 itself as a travel-related illness, which will surely remain a problem into the future. GeoSentinel has already been successful at obtaining supplemental funding from the CDC for a multi-part project which includes sentinel surveillance for COVID-19 and other respiratory infections, pre-and post-travel screening for infection in order to accurately define risk of transmission, and the collection of biomarkers which may be associated with severe disease. Through funds raised by the GeoSentinel Foundation and in collaboration with other agencies, the network was also able to demonstrate the capacity to fund and organize a multi-center adaptive controlled trial of prophylactic regimens for health care workers. Twenty-five years after a small group of practitioners created GeoSentinel around the idea that travel medicine was not only needed to improve the care of travelers but could also be the key to understanding the emergence and movement of illness itself, the network continues to evolve and expand. Travel medicine has turned out to be a unique tool providing insight into the epidemiology and pathogenicity of endemic illness. This venture has become a success not simply by using modern diagnostic and communications resources, but mostly though the dedication, initiative and collaborations among a network of colleagues around the world with a vision that transcended their own borders. The challenge of emerging and re-emerging infectious diseases Emerging infections: a perpetual challenge Global travel patterns: an overview Business travel-associated illness: a GeoSentinel analysis Travel-associated disease among US residents visiting US GeoSentinel clinics after return from international travel Public health threat of new, reemerging, and neglected zoonoses in the industrialized world Managing the health effects of climate change. Lancet and University College London Institute for Global Health Commission Urbanisation and infectious diseases in a globalised world Ecology of zoonoses: natural and unnatural histories Antibiotic resistance-the need for global solutions Access to effective antimicrobials: a worldwide challenge Global geographic trends in antimicrobial resistance: the role of international travel GeoSentinel surveillance of illness in returned travelers Surveillance for travel-related disease-GeoSentinel surveillance system Leptospirosis in "ecochallenge" athletes, Malaysian Borneo Update: outbreak of acute febrile illness among athletes participating in eco-challenge-Sabah Spectrum of disease and relation to place of exposure among ill returned travelers Rabies post-exposure prophylaxis started during or after travel: a GeoSentinel analysis International mass gatherings and travel-associated illness: a GeoSentinel cross-sectional, observational study Unplanned healthcare during travel: a descriptive analysis from the GeoSentinel Network Global surveillance of infectious diseases in migrants by the GeoSentinel network Sentinel surveillance in travel medicine: 20 years of GeoSentinel publications (1999-2018) Cutaneous and mucocutaneous leishmaniasis in travellers and migrants: a 20-year GeoSentinel surveillance network analysis Bordetella pertussis infections in travelers: data from the GeoSentinel global network Clostridium difficile infection in returning travellers Leptospirosis among returned travelers: a GeoSentinel site survey and multicenter analysis -1997 -2016 Travel-related hepatitis E: a two-decade GeoSentinel analysis Epidemiological and clinical characteristics of international travelers with enteric fever and antibiotic resistance profiles of their isolates: a GeoSentinel analysis Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the Geosentinel surveillance network Infectious diseases acquired by international travellers visiting the USA Illness in travelers returned from Brazil: the geosentinel experience and implications for the 2014 FIFA world cup and the 2016 summer olympics Illness among US resident student travellers after return to the USA: a GeoSentinel analysis Illness in travelers visiting friends and relatives: a review of the GeoSentinel surveillance network Travel-associated infection presenting in Europe (2008-12): an analysis of EuroTravNet longitudinal, surveillance data, and evaluation of the effect of the pre-travel consultation Dermatoses among returned Canadian travellers and immigrants: surveillance report based on CanTravNet data Traveller exposures to animals: a GeoSentinel analysis Spectrum of illness in international migrants seen at GeoSentinel clinics in 1997-2009, part 1: US-bound migrants evaluated by comprehensive protocolbased health assessment Profile of illness in Syrian refugees: a GeoSentinel analysis Area of exposure and treatment challenges of malaria in Eritrean migrants: a GeoSentinel analysis Travel-associated Zika virus disease acquired in the americas through February 2016: a GeoSentinel analysis Zika beyond the Americas: Travelers as sentinels of Zika virus transmission. A GeoSentinel analysis Measles in the 21st century, a continuing preventable risk to Travelers: data from the GeoSentinel global network The rise in travel-associated measles infections-GeoSentinel, 2015-2019 Detection on four continents of dengue fever cases related to an ongoing outbreak in Luanda Acute muscular sarcocystosis: an international investigation among ill travelers returning from Local and international implications of schistosomiasis acquired in Corsica Fatal yellow fever in travelers to Brazil Chikungunya resurgence in the Maldives and risk for importation via tourists to Europe in 2019-2020: a GeoSentinel case series Travel-associated chikungunya acquired in Myanmar in 2019 Increased risk of chikungunya infection in travellers to Thailand during ongoing outbreak in tourist areas: cases imported to Europe and the Middle East Fever in returned travelers: results from the GeoSentinel surveillance network Malaria in travelers: a review of the GeoSentinel surveillance network Increased risk of yellow fever infections among unvaccinated European travellers due to ongoing outbreak in Brazil Ongoing outbreak of an acute muscular Sarcocystis-like illness among travellers returning from Zika virus infection in a Massachusetts resident after travel to Costa Rica: a case report GeoSentinel, the Global Surveillance Network of the International Society of Travel Medicine (ISTM), is supported by Cooperative Agreement 5 NU50CK000478-02-00 from the Centers for Disease Control and Prevention (CDC), as well as the ISTM and Public Health Agency of Canada (PHAC). DHH, AR, DOF and ML each drafted sections of the initial draft. All authors reviewed and provided input on the final versions of the manuscript. Drs Hamer and Libman, and Ms Rizwan receive salary support from GeoSentinel through subcontracts from ISTM.